EP3400007A4 - Orthomyxo-like virus of tilapia - Google Patents

Orthomyxo-like virus of tilapia Download PDF

Info

Publication number
EP3400007A4
EP3400007A4 EP17735934.6A EP17735934A EP3400007A4 EP 3400007 A4 EP3400007 A4 EP 3400007A4 EP 17735934 A EP17735934 A EP 17735934A EP 3400007 A4 EP3400007 A4 EP 3400007A4
Authority
EP
European Patent Office
Prior art keywords
orthomyxo
tilapia
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP17735934.6A
Other languages
German (de)
French (fr)
Other versions
EP3400007A1 (en
Inventor
Arnon Dishon
Shlomit TAL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abic Biological Laboratories Ltd
Original Assignee
Abic Biological Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abic Biological Laboratories Ltd filed Critical Abic Biological Laboratories Ltd
Publication of EP3400007A1 publication Critical patent/EP3400007A1/en
Publication of EP3400007A4 publication Critical patent/EP3400007A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP17735934.6A 2016-01-10 2017-01-10 Orthomyxo-like virus of tilapia Withdrawn EP3400007A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662276873P 2016-01-10 2016-01-10
US201662352570P 2016-06-21 2016-06-21
PCT/IL2017/050027 WO2017118989A1 (en) 2016-01-10 2017-01-10 Orthomyxo-like virus of tilapia

Publications (2)

Publication Number Publication Date
EP3400007A1 EP3400007A1 (en) 2018-11-14
EP3400007A4 true EP3400007A4 (en) 2019-08-28

Family

ID=59274499

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17735934.6A Withdrawn EP3400007A4 (en) 2016-01-10 2017-01-10 Orthomyxo-like virus of tilapia

Country Status (6)

Country Link
EP (1) EP3400007A4 (en)
CN (1) CN108778324A (en)
BR (1) BR112018014042A2 (en)
CO (1) CO2018008288A2 (en)
MX (1) MX2018008529A (en)
WO (1) WO2017118989A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108624718A (en) * 2018-06-20 2018-10-09 上海海洋大学 Constant temperature detects the RPA kits and its primer special and probe of Tilapia mossambica lake virus in real time
CA3167972A1 (en) 2020-02-17 2021-08-26 Assaf LOWENTHAL Immune-enhanced aquaculture
CN112194710A (en) * 2020-08-19 2021-01-08 佛山科学技术学院 Recombinant protein coded by tilapia lake virus S8 gene, antibody prepared from recombinant protein and application of recombinant protein
NL2028806B1 (en) * 2021-07-22 2022-06-03 Univ Northwest A&F Tilv-2 protein or gene encoding tilv-2 protein in preparation of subunit vaccine against tilapia lake virus
CN113755645B (en) * 2021-09-30 2023-06-09 厦门海关技术中心 Fluorescent quantitative RT-PCR primer pair and probe for detecting rochu virus, kit and detection method
CN113718061B (en) * 2021-09-30 2023-06-09 厦门海关技术中心 Primer set, kit and method for simultaneously detecting double RT-PCR of rochu virus and viral nervous necrosis virus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL230970A0 (en) * 2014-02-13 2014-09-30 Univ Ramot Tilapia lake virus vaccines
SG10202102695UA (en) * 2014-12-15 2021-04-29 Univ Columbia Novel tilapia virus and uses thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MOSHE LICHTMAN: "St. Peter's Fish endangered in Sea of Galilee", GLOBES, 26 July 2012 (2012-07-26), XP055357636, Retrieved from the Internet <URL:http://www.globes.co.il/en/article-1000769099> [retrieved on 20170322] *
OIE WORLD ORGANISATION FOR ANIMAL HEALTH: "TILAPIA LAKE VIRUS (TiLV )- A NOVEL ORTHOMYCO-LIKE VIRUS", 2 March 2018 (2018-03-02), XP055604355, Retrieved from the Internet <URL:http://www.oie.int/fileadmin/Home/eng/Internationa_Standard_Setting/docs/pdf/Aquatic_Commission/A_TiLV_disease_card.pdf> [retrieved on 20190710] *
See also references of WO2017118989A1 *

Also Published As

Publication number Publication date
CO2018008288A2 (en) 2018-08-21
EP3400007A1 (en) 2018-11-14
WO2017118989A1 (en) 2017-07-13
MX2018008529A (en) 2019-06-06
CN108778324A (en) 2018-11-09
BR112018014042A2 (en) 2019-02-12

Similar Documents

Publication Publication Date Title
AU2016298394C1 (en) Ancestral virus sequences and uses thereof
EP3544607A4 (en) Viral delivery of neoantigens
EP3490574A4 (en) Expression of pten-long with ocolytic viruses
EP3487464A4 (en) Rollator
EP3259246A4 (en) Derivatives of sobetirome
IL286265A (en) Novel tilapia virus and uses thereof
EP3233878A4 (en) Phosphoramidates for the treatment of hepatitis b virus
EP3139920A4 (en) Anti-viral compounds, pharmaceutical compositions, and methods of use thereof
EP3119883A4 (en) Influenza virus vectors and uses therefor
EP3277243A4 (en) Crutch
EP3457851A4 (en) Derivatives of sobetirome
EP3400007A4 (en) Orthomyxo-like virus of tilapia
EP3166615A4 (en) Methods for the treatment of hepatitis b and hepatitis d virus infections
EP3297619A4 (en) Therapeutic uses of l-4-chlorokynurenine
EP3314509A4 (en) Mitigation of malware
EP3227298A4 (en) Process for the preparation of baricitinib and an intermediate thereof
EP3104883A4 (en) Tilapia lake virus vaccines
EP3468578A4 (en) Uses of il-41
EP3268034A4 (en) Non-neuroinvasive viruses and uses thereof
EP3500280A4 (en) Viral vaccines
EP3149024A4 (en) Derivatives of dolaproine-dolaisoleuine peptides
EP3338775A4 (en) Use of butylidenephthalide
EP3269327A4 (en) Arrangement of intrastromal segments
EP3259262A4 (en) Process and intermediates for the preparation of perampanel
EP3149022A4 (en) Virus reduction method

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180730

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ABIC BIOLOGICAL LABORATORIES LTD.

A4 Supplementary search report drawn up and despatched

Effective date: 20190729

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 7/00 20060101ALI20190723BHEP

Ipc: A61P 31/14 20060101ALI20190723BHEP

Ipc: A61K 39/12 20060101AFI20190723BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20200227